Back
Cellectis SA Vs. Biodexa Pharmaceuticals Plc Industry Stock Comparison
Buy
90
CLLS
Cellectis SA
Last Price:
3.07
Seasonality Move:
-2.97%
Sell
26
BDRX
Biodexa Pharmaceuticals Plc
Last Price:
0.93
Seasonality Move:
-23.05%
Buy
90
Cellectis SA (CLLS)
is a Buy
Is Cellectis SA a Buy, Sell or Hold?
- The current Cellectis SA [CLLS] share price is $3.06. The Score for CLLS is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
- CLLS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
26
Biodexa Pharmaceuticals Plc (BDRX)
is a Sell
Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals Plc [BDRX] share price is $0.92. The Score for BDRX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLLS Stock Price Chart
What is Cellectis SA's stock price today?
-
The Cellectis SA share price today is $3.06
The current trend is moderately bullish and CLLS is experiencing selling pressure, which indicates risk of future bearish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals Plc's stock price today?
-
The Biodexa Pharmaceuticals Plc share price today is $0.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.
CLLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 59.1 | Buy |
| Chaikin Money Flow: | -73121 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.48 - 3) | Buy |
| Bollinger Bands (100): | (2.54 - 3.08) | Buy |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 43.81 | Sell |
| Chaikin Money Flow: | -153052 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.8 - 1.2) | Sell |
| Bollinger Bands (100): | (0.94 - 2.08) | Sell |
CLLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.05 | Buy |
| 20-day SMA: | 2.74 | Buy |
| 50-day SMA: | 2.66 | Buy |
| 200-day SMA: | 2.42 | Buy |
| 8-day EMA: | 3.03 | Buy |
| 20-day EMA: | 2.85 | Buy |
| 50-day EMA: | 2.75 | Buy |
| 200-day EMA: | 2.6 | Buy |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.1 | Sell |
| 20-day SMA: | 1 | Sell |
| 50-day SMA: | 1.09 | Sell |
| 200-day SMA: | 3 | Sell |
| 8-day EMA: | 1.04 | Sell |
| 20-day EMA: | 1.05 | Sell |
| 50-day EMA: | 1.18 | Sell |
| 200-day EMA: | 39.34 | Sell |
Cellectis SA Earnings Growth & CLLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and a decrease next year of $1.32 per share.
Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.03 per share.
Cellectis SA Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals Plc Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||